There is evidence that NTHi and Mcat can act as co-pathogens in respiratory tract infections and COPD, as indicated by protection of NTHi from complement-mediated killing via complement resistance factors on outer membrane vesicles produced by Mcat [10]. This evidence concerns the gene MCAT and chronic obstructive pulmonary disease.